Syngenta obtains non-exclusive IP license from Broad Institute for CRISPR-Cas9 genome-editing technology for agriculture applications

• CRISPR-Cas9 technology allows for efficient development of new plant varieties
• Syngenta will use CRISPR-Cas9 technology in various crops, including corn, soy, wheat, tomato, rice and sunflower

Syngenta announced today it has attained a non-exclusive IP license from the Broad Institute of MIT and Harvard for CRISPR-Cas9 genome-editing technology for agricultural applications.

CRISPR-Cas9 genome editing technology complements Syngenta’s already robust plant breeding innovation toolbox. Syngenta is applying this technology in multiple crops, including corn, wheat, tomato, rice and sunflower.

“Gaining access to CRISPR-Cas9 technology will allow us to accelerate the rate of innovation in the development of new plant varieties, and bring novel traits into the hands of growers faster, and with greater efficiency,” said Michiel van Lookeren Campagne, global head of seeds research at Syngenta. “Using this advanced technology will help us deliver on the 21st century food production challenges.”